Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-26-003938·BIODESIX INC
Schedule 13G ownership disclosure
BIODESIX INC
Common Stock, par value $0.001 per share · CUSIP: 09075X207
Event date: 2026-01-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Capital Master Fund, L.P.
Shares: 500,000.00 · Class: 6.3%
- Soleus Capital, LLC
Shares: 500,000.00 · Class: 6.3%
- Soleus Capital Group, LLC
Shares: 500,000.00 · Class: 6.3%
- Soleus Capital Management, L.P.
Shares: 500,000.00 · Class: 6.3%
- Soleus GP, LLC
Shares: 500,000.00 · Class: 6.3%
- Guy Levy
Shares: 500,000.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-003938
- Form type
- SCHEDULE 13G
- Filer
- BIODESIX INC
- CIK
- CIK 1439725
- Filed
- Jan 13, 2026
- Reporting period
- Jan 12, 2026
- Description
- Schedule 13G beneficial ownership